Araştırma Makalesi

The apoptotic paradox in schizophrenia

Cilt: 41 Sayı: 2 30 Haziran 2019
PDF İndir
EN

The apoptotic paradox in schizophrenia

Abstract

Objective: Understanding the role of apoptosis in abnormal neurodevelopment and neurodegenerative processes is crucial. In this study, it is aimed to determine how apoptosis biomarkers are affected in patients with schizophrenia and severity of the disease and also whether apoptosis biomarkers can be used as blood-based biomarkers in diagnosis of the disease.

Method: This is a cross-sectional prospective study performed at a tertiary university hospital and city hospital in Turkey. Volunteers (n=60) diagnosed with schizophrenia were divided into three groups (Mild, Moderate and Severe) according to the Clinical Global Impressions Scale developed by Guy. The control group was constituted from volunteers who were similar to the patient group (n=40) in terms of age and gender. Serum levels of Caspase-8(C-8), Granzyme B (GrB) and Cytcochrome C (CYCS) were measured by ELISA method from blood samples collected from patient and control groups.

Results: It was observed that Caspase 8 and GrB levels were lower in all three groups compared with the control group, and the highest decrease was in the 3rd group (P<0,.5). CYCS level on the other hand increased, and the highest increase was observed in 3rd Group (P<0.05).

Conclusions: It is hypothesised that increase in serum CYCS level of patients with schizophrenia may be a blood based biomarker in which apoptosis occurs.      

Keywords

Kaynakça

  1. References1- Öztürk MO, Uluşahin NA. Ruh Sağlığı ve Bozuklukları (14. baskı). Ankara: Nobel tıp kitabevleri; 2016.S:242-243.
  2. 2- Yavuz R. Şizofreni İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri 2008 S:49-58.
  3. 3- Velásquez E, Nogueira FCS, Velásquez I, Schmitt A, Falkai P, Domont GB, et.al. Synaptosomal Proteome of the Orbitofrontal Cortexfrom Schizophrenia Patients Using Quantitative Label-Freeandi TRAQ-Based Shotgun Proteomics J Proteome Res. 2017:1;16(12):4481-4494.
  4. 4- Soygür H, Alptekin K, Atbaşoğlu EC, Herken H. Şizofreni ve Diğer Psikotik Bozukluklar. Ankara: Türkiye Psikiyatri Derneği; 2007. S:12
  5. 5- Vyas NS, Patel NH, Nijran KS, Al-Nahhas A, Puri BK. Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia? Nucl Med Commun 2010;31(2):91-93.
  6. 6- Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001;49:(1-2):1-52. 7- Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. American Journal of Psychiatry 2004;161(1):109-115.
  7. 8- Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol. 2008;9(7):532–542.
  8. 9- Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000;407(6805):802-809.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

30 Haziran 2019

Gönderilme Tarihi

13 Haziran 2019

Kabul Tarihi

24 Haziran 2019

Yayımlandığı Sayı

Yıl 1970 Cilt: 41 Sayı: 2

Kaynak Göster

AMA
1.Aydın H, Tekin YK, Erşan S, Yavuz H, Erşan EE. The apoptotic paradox in schizophrenia. CMJ. 2019;41(2):256-262. doi:10.7197/223.vi.577914